Vickers Philip J. Insider Trades

Insider Trading History

Track insider trading activity for Vickers Philip J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $208k 214,400 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 214,400 shares
$1.41
$0.97
AvroBio
AvroBio AVRO
Director
Holding Value $24.7k 17,643 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 17,643 shares
$13.08
$1.40
AvroBio
AvroBio AVRO
Director
Holding Value $24.5k 17,478 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 17,478 shares
$12.72
$1.40
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $39.3k 10,756 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 10,756 shares
$18.12
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $108k 29,722 shares
Last Trade
May 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 28,745 shares
$18.12
$3.65
AvroBio
AvroBio AVRO
Director
Holding Value $6.72k 4,800 shares
Last Trade
Jul 07, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$483k 4,800 shares
$100.68
$1.40
AvroBio
AvroBio AVRO
Director
Holding Value $24.4k 17,438 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 17,438 shares
$115.56
$1.40
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $86.4k 23,663 shares
Last Trade
May 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$323k 11,564 shares
$27.91
$3.65
AvroBio
AvroBio AVRO
Director
Holding Value $19.6k 14,000 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.68M 14,000 shares
$262.92
$1.40
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $71.7k 19,650 shares
Last Trade
May 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349k 18,000 shares
$19.40
$3.65
AvroBio
AvroBio AVRO
Director
Holding Value $13.5k 9,675 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 9,675 shares
$163.20
$1.40
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $49.8k 13,650 shares
Last Trade
May 09, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 13,500 shares
$12.82
$3.65
AvroBio
AvroBio AVRO
Director
Holding Value $26.2k 18,743 shares
Last Trade
Jan 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.55M 18,743 shares
$189.36
$1.40
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $33.4k 9,150 shares
Last Trade
May 10, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$262k 9,000 shares
$29.15
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $22.4k 6,150 shares
Last Trade
Mar 16, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$98.4k 3,150 shares
$31.24
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $21.9k 6,000 shares
Last Trade
May 11, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 9,000 shares
$20.90
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $29.2k 8,000 shares
Last Trade
May 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 8,000 shares
$16.63
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $29.2k 8,000 shares
Last Trade
May 07, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 8,000 shares
$20.42
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $65.7k 18,000 shares
Last Trade
Feb 26, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 18,000 shares
$16.46
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up